SK hynix Announces 1Q25 Financial Results
Revenues at 17.6391 trillion won, operating profit at 7.4405 trillion won, net profit at 8.1082 trillion won Both revenues, operating profit achieve 2nd highest... Read more.
NASA Astronaut to Answer Questions from Students in California
WASHINGTON, April 23, 2025 /PRNewswire/ — Students from Santa Monica, California, will connect with NASA astronaut Jonny Kim as he answers prerecorded science,... Read more.
Montrose Environmental Group Awarded $4M AUD Environmental Services Contract for Major Mining Operation in Australia
Project supports rapidly growing global steel demand with scalable, sustainable solutions SYDNEY, April 23, 2025 /PRNewswire/ — Montrose Environmental Group... Read more.
Altus Nova Unveils Proprietary AI Assistant “ANA,” Transforming How Client Solutions Are Delivered
AUSTIN, Texas, April 23, 2025 /PRNewswire/ — Altus Nova Technologies, a product and technology consulting firm known for solving complex software challenges,... Read more.
Premier ASIC and SoC Design Partner Rebrands as Aion Silicon
Trusted Semiconductor Design Partner Combines Deep Expertise with a Fresh Vision to Deliver High-Performance Custom Chip Solutions for AI, Automotive, 5G, networking,... Read more.
LivePerson to Announce First Quarter 2025 Financial Results on May 7, 2025
NEW YORK, April 23, 2025 /PRNewswire/ — LivePerson, Inc. (Nasdaq: LPSN), a leading provider of trusted enterprise conversational AI and outcome-driven digital... Read more.
Best Online Casinos USA: Black Lotus Casino Rated Best U.S. Real Money Casino
NEW YORK, April 23, 2025 /PRNewswire/ — Black Lotus Casino, an online gaming platform that offers real-money casino games to players in the United States and... Read more.
Superwomen Of FMS Leadership Award Nominations Now Open
Calling All Innovators: Recognize Exceptional Women in Memory and Storage SANTA CLARA, Calif., April 23, 2025 /PRNewswire/ — FMS: the Future of Memory and... Read more.
New England Journal of Medicine Publishes Positive Results from Insmed’s Pivotal Phase 3 ASPEN Study of Brensocatib in Patients with Bronchiectasis
—Largest Global Clinical Trial Ever Conducted in Bronchiectasis Demonstrates Statistically Significant and Clinically Meaningful Reduction in Frequency of Pulmonary... Read more.
ConnectM Receives Nasdaq Notice on Late Filing of its Form 10-K
MARLBOROUGH, Mass., April 23, 2025 /PRNewswire/ — ConnectM Technology Solutions, Inc. (Nasdaq: CNTM) (“ConnectM” or the “Company“),... Read more.